Press Releases

April 4, 2024
Parexel Named “Best Contract Research Organization” at 17th Annual Vaccine Industry Excellence (ViE) Awards
Read more
April 4, 2024
Parexel Named “Best Contract Research Organization” at 17th Annual Vaccine Industry Excellence (ViE) Awards
Company recognized by a distinguished industry advisory board for its expertise and leadership in supporting the development of vaccines
Read More
March 18, 2024
Parexel Announces CEO Succession Plan
Chief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024; Mr. Macdonald to retire as CEO and continue on the Board of Directors through Dec. 31, 2024
Read More
February 1, 2024
Parexel Appoints Susan R. Salka to Board of Directors
Ms. Salka brings more than 30 years of healthcare leadership and staffing expertise, including strong C-suite, financial and ESG expertise to advance the company’s Patients-first focus and growth initiatives.
Read More
January 10, 2024
Parexel and Japanese Foundation for Cancer Research Announce Strategic Alliance
Collaboration streamlines patient access to oncology clinical trials further expands Parexel's Site Alliance Network across Asia/Pacific
Read More